EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling

Xianghong Xie iD, Mingyue Gao, Wei Zhao, Chunmei Li, Weihong Zhang, Jiahui Yang, Yinliang Zhang, Enhui Chen, Yanfang Guo, Zeyu Guo, Minglong Zhang, Ebenezeri Erasto Ngowi und 11 weitere

eLife · 22.10.2024 · 13

DOI: 10.7554/elife.96988 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 22.10.2024. Verfasst von Xianghong Xie und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biology, State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Scie…. Hauptthemen laut MEDLINE: Diet, High-Fat, PPAR gamma, RNA, Long Noncoding, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, Beijing Natural Science Foundation, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LncRNAs are involved in modulating the individual risk and the severity of progression in metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. This study aimed to investigate the role of lncRNA Snhg3 in the development and progression of MASLD, along with the underlying mechanisms. The result showed that Snhg3 was significantly downregulated in the liver of high-fat diet-induced obesity (DIO) mice. Notably, palmitic acid promoted the expression of Snhg3 and overexpression of Snhg3 increased lipid accumulation in primary hepatocytes. Furthermore, hepatocyte-specific Snhg3 deficiency decreased body and liver weight, alleviated hepatic steatosis and promoted hepatic fatty acid metabolism in DIO mice, whereas overexpression induced the opposite effect. Mechanistically, Snhg3 promoted the expression, stability and nuclear localization of SND1 protein via interacting with SND1, thereby inducing K63-linked ubiquitination modification of SND1. Moreover, Snhg3 decreased the H3K27me3 level and induced SND1-mediated chromatin loose remodeling, thus reducing H3K27me3 enrichment at the Pparg promoter and enhancing PPARγ expression. The administration of PPARγ antagonist T0070907 improved Snhg3 -aggravated hepatic steatosis. Our study revealed a new signaling pathway, Snhg3 /SND1/H3K27me3/PPARγ, responsible for mice MASLD and indicates that lncRNA-mediated epigenetic modification has a crucial role in the pathology of MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-FatPPAR gammaRNA, Long NoncodingSignal TransductionAnimalsMaleMiceFatty LiverHepatocytesLiverMice, Inbred C57BL

Stichwörter der Autor:innen

PPARγSnhg3chromosomesgene expressionmedicinemetabolic dysfunction-associated fatty liver diseasemouse

Substanzen

PPAR gammaRNA, Long NoncodingPparg protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry & Molecular Biology, State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences & School of Basic Medicine Pe…
  • Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, China.
  • Department of Pathophysiology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences & School of Basic Medicine Peking Union Medical College, Beijing, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China.
  • State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

ORCID-Profile: Xianghong Xie, Heping Wang, Meixia Li, Aijun Qiao, Xiaojun Liu

Förderung

  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • Beijing Natural Science Foundation
  • National Key R&D Program of China
  • the National Natural Science Foundation of China
  • High-level New R&D Institute of Department of Science and Technology of Guangdong Province
  • High-level Innovative Research Institute of Department of Science and Technology of Guangdong Province

Zitieren

APA

Xie, X., Gao, M., Zhao, W., Li, C., Zhang, W., Yang, J., Zhang, Y., Chen, E., Guo, Y., Guo, Z., Zhang, M., Ngowi, E. E., Wang, H., Wang, X., Zhu, Y., Wang, Y., Li, X., Yao, H., Yan, L., …, & Liu, X. (2024). LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling. eLife, 13. https://doi.org/10.7554/elife.96988

Vancouver

Xie X, Gao M, Zhao W, Li C, Zhang W, Yang J, et al. LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling. eLife. 2024;13. doi:10.7554/elife.96988

BibTeX
@article{Xie2024,
  author = {Xie, Xianghong and Gao, Mingyue and Zhao, Wei and Li, Chunmei and Zhang, Weihong and Yang, Jiahui and Zhang, Yinliang and Chen, Enhui and Guo, Yanfang and Guo, Zeyu and Zhang, Minglong and Ngowi, Ebenezeri Erasto and Wang, Heping and Wang, Xiaoman and Zhu, Yinghan and Wang, Yiting and Li, Xiaolu and Yao, Hong and Yan, Li and Fang, Fude and Li, Meixia and Qiao, Aijun and Liu, Xiaojun},
  title = {LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.96988}
}
Kostenlos starten →